Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Baxter
Merck
Colorcon
Fish and Richardson
Johnson and Johnson
US Department of Justice
Farmers Insurance
Dow
Fuji

Generated: December 12, 2017

DrugPatentWatch Database Preview

Lundbeck Pharms Llc Company Profile

« Back to Dashboard

What is the competitive landscape for LUNDBECK PHARMS LLC, and when can generic versions of LUNDBECK PHARMS LLC drugs launch?

LUNDBECK PHARMS LLC has five approved drugs.

There are six US patents protecting LUNDBECK PHARMS LLC drugs.

There are fifty-four patent family members on LUNDBECK PHARMS LLC drugs in nineteen countries.

Summary for Lundbeck Pharms Llc

International Patents:54
US Patents:6
Tradenames:3
Ingredients:3
NDAs:5
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Lundbeck Pharms LlcCARNEXIVcarbamazepineSOLUTION;IV (INFUSION)206030-001Oct 7, 2016RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Lundbeck Pharms LlcSABRILvigabatrinTABLET;ORAL020427-001Aug 21, 2009RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Lundbeck Pharms LlcSABRILvigabatrinFOR SOLUTION;ORAL022006-001Aug 21, 2009AARXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Lundbeck Pharms LlcCARNEXIVcarbamazepineSOLUTION;IV (INFUSION)206030-001Oct 7, 2016RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Lundbeck Pharms LlcSABRILvigabatrinFOR SOLUTION;ORAL022006-001Aug 21, 2009AARXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Lundbeck Pharms LlcCARNEXIVcarbamazepineSOLUTION;IV (INFUSION)206030-001Oct 7, 2016RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Lundbeck Pharms LlcSABRILvigabatrinTABLET;ORAL020427-001Aug 21, 2009RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Lundbeck Pharms LlcONFIclobazamTABLET;ORAL202067-001Oct 21, 2011DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Lundbeck Pharms LlcSABRILvigabatrinFOR SOLUTION;ORAL022006-001Aug 21, 2009AARXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Lundbeck Pharms LlcONFIclobazamTABLET;ORAL202067-003Oct 21, 2011RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Lundbeck Pharms Llc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,200,088Sulfoalkyl ether cyclodextrin compositions► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Lundbeck Pharms Llc Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2007041524► Subscribe
Canada2771879► Subscribe
Mexico2010004900► Subscribe
China101309691► Subscribe
Australia2016210707► Subscribe
Slovenia1928464► Subscribe
European Patent Office1928464► Subscribe
Eurasian Patent Organization201000828► Subscribe
BrazilPI0905080► Subscribe
European Patent Office2444090► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
McKesson
Argus Health
QuintilesIMS
Cantor Fitzgerald
Boehringer Ingelheim
AstraZeneca
Fish and Richardson
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot